Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Personalised T Cell Activator Shows Promise
February 2026
A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.
Read more
7
Mins
15 Jul 2024
‘IMROZ’ Study – Clinical Implications
Despite what Mohty described as “progressive advances in the field” over recent years, significant unmet needs remain in the front-line…
14 Jul 2024
New Insights into Neutrophils’ Role in CAR-T Therapy Complications
Recent research suggests that neutrophils may play a crucial role in cytokine release syndrome, a severe and life-threatening side effect of CAR-T therapy.
12 Jul 2024
Potential of JAK Inhibitors with Immunotherapy as Cancer Treatment
New research shows the role of JAK inhibitors in boosting immune responses against cancer.
11 Jul 2024
Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute Myeloid Leukemia and Myelofibrosis
Catch up on this expert-led Satellite Symposium, titled ‘Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute…
10 Jul 2024
Ruxolitinib Effective for Steroid-Refractory Graft-Versus-Host Disease
New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.
9 Jul 2024
Phase III IMROZ Study of Isa-VRd in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Watch Thierry Facon highlight the Phase III IMROZ study: a global, randomised, Phase III, open-label study evaluating the efficacy and…
7 Jul 2024
Importance of Circulating Tumour Cells in Multiple Myeloma Risk Stratification
A study has highlighted the clinical significance of circulating tumour cells in the blood of multiple myeloma patients, proposing a new cutoff that could enhance treatment outcomes.
6 Jul 2024
New Program Eases Distress and Fatigue in Blood Cancer Patients
A new program has shown promising results in reducing distress and fatigue among blood cancer patients who have undergone haematopoietic stem cell transplants.
Loading posts...
« Previous
1
…
42
43
44
45
46
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View